{"bill": {"#text": " \n", "form": {"current-chamber": {"#tail": " \n", "@display": "no", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n", "congress": {"#tail": " ", "#text": "113th CONGRESS"}, "#tail": " \n", "legis-num": {"#tail": " \n", "#text": "H. R. 4709"}, "official-title": {"#tail": " \n", "@display": "yes", "#text": "To improve enforcement efforts related to prescription drug diversion and abuse, and for other purposes."}, "session": {"#tail": " \n", "#text": "2d Session"}, "distribution-code": {"#tail": " \n", "@display": "no", "#text": "I"}, "legis-type": {"#tail": " \n", "#text": "AN ACT"}}, "attestation": {"#tail": "\n", "attestation-group": {"#tail": "\n  ", "role": {"#tail": "\n    ", "#text": "Clerk."}, "#text": "\n      ", "attestor": {"#tail": "\n      ", "@display": "no", "#text": "Karen L. Haas,"}, "attestation-date": {"#tail": "\n      ", "@date": "20140729", "#text": "Passed the House of Representatives July 29, 2014.", "@chamber": "House"}}, "#text": "\n    "}, "@stage-count": "1", "@bill-stage": "Engrossed-in-House", "@bill-type": "olc", "endorsement": {"#tail": "\n", "@display": "yes"}, "@dms-id": "HEA367D0501F54DFE8B821C161D1C78A9", "@public-private": "public", "legis-body": {"#tail": " ", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": " \n", "text": {"#tail": "\n    ", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Ensuring Patient Access and Effective Drug Enforcement Act of 2014", "@value": "Ensuring Patient Access and Effective Drug Enforcement Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H71FB06D9A0A94926B887E5BE1E538C12"}, {"#tail": " \n", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": " \n", "#text": "Registration process under Controlled Substances Act"}, "subsection": [{"#tail": " \n", "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": " \n", "#text": "Definitions"}, "paragraph": [{"#tail": " \n", "text": {"#tail": " \n", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 303 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:303"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 823", "@value": "usc/21/823"}, "@parsable-cite": "usc/21/823", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "Factors as may be relevant to and consistent with the public health and safety"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n        ", "subsection": {"#tail": "\n            ", "text": {"{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "section 101", "@value": "Controlled Substances Act/s:101"}, "quote": {"#tail": " means factors that are relevant to and consistent with the findings contained in ", "#text": "factors as may be relevant to and consistent with the public health and safety"}, "#tail": "\n            ", "#text": "In this section, the phrase ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(i)"}, "@id": "HC569CBA06D4C441EBBFAD425B60CF527", "#text": "\n              "}, "@display-inline": "no-display-inline", "#text": " \n", "@id": "H363843CE43714E49AB156F60AAB21DB1"}, "#text": "\n          ", "@id": "H22FA1DC728154998BCE7EE52F234919D"}, {"#tail": "\n      ", "@id": "H900618BBCC944BB8BCC639DC372E5130", "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Imminent danger to the public health or safety"}, "text": {"#tail": " \n", "#text": "\n            ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 304(d) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:304/ss:d"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 824(d)", "@value": "usc/21/824/d"}, "@parsable-cite": "usc/21/824", "#text": "\n              ", "@legal-doc": "usc"}}}, "#text": "\n          ", "subparagraph": [{"#tail": " \n", "text": {"#tail": "\n          ", "quote": [{"#tail": " and inserting ", "#text": "(d) The Attorney General\n              "}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " The ", "@entity-type": "act", "#text": "(d)(1)", "@value": "Controlled Substances Act/s:304/ss:d/p:1", "@proposed": "true"}, {"#tail": "\n              ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}], "#text": "\n                "}], "#text": "by striking "}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "HEFBB9A0247584D26BEC2EB0DCCD49C04", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": " \n", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "."}, "#tail": "\n          ", "paragraph": {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": " \n", "term": {"#tail": " means that, in the absence of an immediate suspension order, controlled substances\u2014", "#text": "imminent danger to the public health or safety"}, "#text": "In this subsection, the phrase ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                ", "#text": "(2)"}, "#text": "\n                ", "@id": "H7C924D2D4300454084F72F687BDFFECE", "subparagraph": [{"#tail": " \n", "text": {"#tail": " \n", "#text": "will continue to be intentionally distributed or dispensed\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(A)"}, "clause": [{"#tail": " \n", "text": {"#tail": "\n                  ", "#text": "outside the usual course of professional practice; or", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n                    ", "#text": "(i)"}, "@id": "H1933648CFE944D5894A5B487CDF1D4CB", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n                  ", "#text": "in a manner that poses a present or foreseeable risk of serious adverse health consequences or death; or"}, "enum": {"#tail": "\n                    ", "#text": "(ii)"}, "@id": "HCF562A9AA6B149ACB1D1F95A9ED5A77F", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H45E8BDFF0DE14BEB83E02C0F6891DB51"}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "#text": "will continue to be intentionally diverted outside of legitimate distribution channels."}, "enum": {"#tail": "\n                  ", "#text": "(B)"}, "@id": "HED94D6D1A1C14007A40275E037425DE7", "#text": "\n                  "}]}, "@display-inline": "no-display-inline", "#text": " \n", "@id": "HDEF025DDA7BA4A52B7C7F6B6761B987D"}, "#text": "\n            ", "@id": "H4138CA7EE7C94012821D34183B7874E5"}]}], "#text": "\n        ", "@id": "H5306A535106842CEA7168B562BABAC6E"}, {"#tail": "\n    ", "text": {"#tail": " \n", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Subsection (c) of section 304 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:304/ss:c"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 824", "@value": "usc/21/824"}, "@parsable-cite": "usc/21/824", "#text": "\n            ", "@legal-doc": "usc"}}, "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Opportunity To submit corrective action plan prior to revocation or suspension"}, "paragraph": [{"#tail": " \n", "text": {"#tail": "\n        ", "#text": "by striking the last two sentences in such subsection;"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HF86ED9E88D30482C87DB31431C217892", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "quote": [{"#tail": " and inserting ", "#text": "(c) Before"}, {"#tail": "; and", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " Before", "@entity-type": "act", "#text": "(c)(1)", "@value": "Controlled Substances Act/s:304/ss:c/p:1", "@proposed": "true"}, "#text": "\n              "}], "#text": "by striking "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H01F77CA56680471B96B9E7936C123503", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": " \n", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n        ", "paragraph": [{"@indent": "up1", "#tail": " \n", "text": {"#tail": " \n", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall\u2014", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Controlled Substances Act/s:304/ss:c/p:1", "@proposed": "true"}, "#text": "An order to show cause under "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "#text": "\n              ", "@id": "H818C725CA32941F5AE4C7B4FF743064F", "subparagraph": [{"#tail": " \n", "text": {"#tail": "\n              ", "#text": "contain a statement of the basis for the denial, revocation, or suspension, including specific citations to any laws or regulations alleged to be violated by the applicant or registrant;"}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H7DC04F26446D43BBA5C365797A994BA4", "#text": "\n                "}, {"#tail": " \n", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " at a time and place stated in the order, but no less than thirty days after the date of receipt of the order; and", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, "#text": "direct the applicant or registrant to appear before the "}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H58F9BAD54DF947388CBCFC0074A7E79F", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n              ", "#text": "notify the applicant or registrant of the opportunity to submit a corrective action plan on or before the date of appearance."}, "enum": {"#tail": "\n                ", "#text": "(C)"}, "@id": "H81EBEE957CBB4B5193ABFB19D42B4A03", "#text": "\n                "}]}, {"@indent": "up1", "#tail": " \n", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", the ", "@entity-type": "act", "#text": "paragraph (2)", "@value": "Controlled Substances Act/s:304/ss:c/p:2", "@proposed": "true"}, {"#tail": " shall determine whether denial, revocation or suspension proceedings should be discontinued, or deferred for the purposes of modification, amendment, or clarification to such plan.", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}], "#text": "Upon review of any corrective action plan submitted by an applicant or registrant pursuant to "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "#text": "\n              ", "@id": "HDDAEB68EE86C46EF846AD61851444FFE"}, {"@indent": "up1", "#tail": " \n", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ". Such proceedings shall be independent of, and not in lieu of, criminal prosecutions or other proceedings under this title or any other law of the United States.", "@entity-type": "uscode", "#text": "subchapter II of ", "external-xref": {"#tail": " of title 5", "@parsable-cite": "usc-chapter/5/5", "#text": "chapter 5", "@legal-doc": "usc-chapter"}, "@value": "usc-chapter/5/5/II"}, "#text": "Proceedings to deny, revoke, or suspend shall be conducted pursuant to this section in accordance with "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "#text": "\n              ", "@id": "HC341FA78C8EC4E3CBB1E42489F7E23F6"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n            ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ".", "@entity-type": "act", "#text": "subsection (d)", "@value": "Controlled Substances Act/s:304/ss:d"}, "#text": "The requirements of this subsection shall not apply to the issuance of an immediate suspension order under "}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "#text": "\n              ", "@id": "H36C826AE1CBE4AFE9602499F09552B68"}], "@display-inline": "no-display-inline", "#text": " \n", "@id": "H14A81C371A124B00B74C1BB759D2A90F"}, "#text": "\n          ", "@id": "H96F65A1C309343CEB8A271E50783F677"}], "#text": "\n        ", "@id": "H919D5C29D791499D832B0BC019DE76A9"}], "#text": "\n      ", "@id": "HCE607419F1D34D6EB8A11EC312ECD226"}, {"#tail": " \n", "enum": {"#tail": "\n      ", "#text": "3."}, "header": {"#tail": " \n", "#text": "Report to Congress on effects of law enforcement activities on patient access to medications"}, "subsection": [{"#tail": " \n", "text": {"#tail": " \n", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", acting through the ", "@entity-type": "federal-body", "#text": "Secretary of Health and Human Services", "@entity-id": "7500"}, {"#tail": " and the ", "@entity-type": "federal-body", "#text": "Commissioner of Food and Drugs", "@entity-id": "7524"}, {"#tail": ", and in consultation with the ", "@entity-type": "federal-body", "#text": "Director of the Centers for Disease Control and Prevention", "@entity-id": "7523"}, {"#tail": " and the ", "@entity-type": "federal-body", "#text": "Administrator of the Drug Enforcement Administration", "@entity-id": "1524"}, {"#tail": ", shall submit a report to the ", "@entity-type": "federal-body", "#text": "Director of National Drug Control Policy", "@entity-id": "1127"}, {"#tail": ", the ", "@entity-type": "committee", "#text": "Committees on the Judiciary of the House of Representatives", "@entity-id": "HJU00"}, {"#tail": ", the ", "@entity-type": "committee", "#text": "Committee on Energy and Commerce of the House of Representatives", "@entity-id": "HIF00"}, {"#tail": ", and the ", "@entity-type": "committee", "#text": "Committee on the Judiciary of the Senate", "@entity-id": "SSJU00"}, {"#tail": " identifying\u2014", "@entity-type": "committee", "#text": "Committee on Health, Education, Labor and Pensions of the Senate", "@entity-id": "SSHR00"}], "#text": "Not later than one year after the date of enactment of this Act, the ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "In general"}, "paragraph": [{"#tail": " \n", "text": {"#tail": "\n        ", "#text": "obstacles to legitimate patient access to controlled substances;"}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "HD2C44B04DD6A410D90EAD7172EA7BEFB", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "#text": "issues with diversion of controlled substances; and"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H2BC13C38B23E48C98ADC53AE2A19F530", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "how collaboration between Federal, State, local, and tribal law enforcement agencies and the pharmaceutical industry can benefit patients and prevent diversion and abuse of controlled substances."}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H21717A3FD57A44448BD166B441E02C96", "#text": "\n          "}], "#text": "\n        ", "@id": "HFD8E94DA3E174658B6776898F6C155B7"}, {"#tail": "\n    ", "text": {"#tail": " \n", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall incorporate feedback and recommendations from the following:", "@entity-type": "act", "#text": "subsection (a)", "@value": "Ensuring Patient Access and Effective Drug Enforcement Act of 2014/s:3/ss:a", "@proposed": "true"}, "#text": "The report under ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Consultation"}, "paragraph": [{"#tail": " \n", "text": {"#tail": "\n        ", "#text": "Patient groups."}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "@id": "H092E27C086584A9FB8D1B652B975F6FD", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "#text": "Pharmacies."}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "@id": "H5CD65F75C12849BDA6D28D3B4B888192", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "#text": "Drug manufacturers."}, "enum": {"#tail": "\n          ", "#text": "(3)"}, "@id": "H9469E001598C4B808B8554CF74A3EAE5", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "#text": "Common or contract carriers and warehousemen."}, "enum": {"#tail": "\n          ", "#text": "(4)"}, "@id": "H4C1B8E43FFE643FE9E5FAFB80C1C3D6B", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "#text": "Hospitals, physicians, and other health care providers."}, "enum": {"#tail": "\n          ", "#text": "(5)"}, "@id": "HECACCE814CF34A90AD1D19D19CAA8931", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "#text": "State attorneys general."}, "enum": {"#tail": "\n          ", "#text": "(6)"}, "@id": "HA5BEFFAC62054C27B0C0FFC7FA48F57C", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "#text": "Federal, State, local, and tribal law enforcement agencies.", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n          ", "#text": "(7)"}, "@id": "H44FB8066A4584465AEAB20596F6A349C", "#text": "\n          "}, {"#tail": " \n", "text": {"#tail": "\n        ", "#text": "Health insurance providers and entities that provide pharmacy benefit management services on behalf of a health insurance provider."}, "enum": {"#tail": "\n          ", "#text": "(8)"}, "@id": "HBF1D70DCC8A34E7098D1B9295EF8D2CF", "#text": "\n          "}, {"#tail": "\n      ", "text": {"#tail": "\n        ", "#text": "Wholesale drug distributors."}, "enum": {"#tail": "\n          ", "#text": "(9)"}, "@id": "HF98C2C07D6FB4FB9A1007FC08F5C1729", "#text": "\n          "}], "#text": "\n        ", "@id": "H7DED1A4A89A7442EA504E8EC24DF85E9"}], "#text": "\n      ", "@id": "HA72B90AD1F004BD59C5A71765787DF1B"}], "#text": " \n", "@id": "HAEF97E493D1940C693F84A1B5D02C1F7"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4709 EH: Ensuring Patient Access and Effective Drug Enforcement Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}